0001104659-15-065272.txt : 20150915 0001104659-15-065272.hdr.sgml : 20150915 20150915163052 ACCESSION NUMBER: 0001104659-15-065272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150911 FILED AS OF DATE: 20150915 DATE AS OF CHANGE: 20150915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc. CENTRAL INDEX KEY: 0001626199 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208969493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-945-7700 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Congleton Jon CENTRAL INDEX KEY: 0001644975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37449 FILM NUMBER: 151108023 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 4 1 a4.xml 4 X0306 4 2015-09-11 0 0001626199 Nivalis Therapeutics, Inc. NVLS 0001644975 Congleton Jon C/O NIVALIS THERAPEUTICS, INC. 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 1 1 0 0 President and CEO Stock Option (Right to Buy) 15.28 2015-09-11 4 A 0 121100 0 A 2025-09-11 Common Stock 121100 121100 D The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. The options vest and become exercisable over a four-year period, with 25% vesting on the first anniversary of the grant date (September 11, 2016) and 1/48th of the options vesting monthly thereafter. /s/ R. Michael Carruthers, Attorney-in-Fact 2015-09-15